论文部分内容阅读
目的研究在综合性基础治疗的基础上加用普米克、沐舒坦、孟鲁司特治疗小儿慢性咳嗽的疗效。方法将患儿随机分为对照组和治疗组,每组各50例,对照组按综合性基础治疗;治疗组在综合性基础治疗的基础上加用沐舒坦、普米克令舒、孟鲁司特治疗,疗程为一周。结果治疗组患儿的临床疗效明显优于对照组患儿的临床疗效,χ2=14.66,P<0.005,有统计学意义。结论普米克、沐舒坦、孟鲁司特三种药物的联合使用可更有效地抑制气道慢性炎症,对降低气道高反应性,促进气管内的痰液稀释排出有着显著的作用,从而能有效地控制咳嗽症状。
Objective To study the curative effect of applying Pulmicort, Mucosolvan and Montelukast on children with chronic cough on the basis of comprehensive basic treatment. Methods The children were randomly divided into control group and treatment group, 50 cases in each group. The control group was treated by comprehensive basic therapy. The treatment group was treated with mucosolvan, Special treatment, treatment for a week. Results The clinical efficacy of the treatment group was significantly better than that of the control group, χ2 = 14.66, P <0.005, with statistical significance. Conclusions The combined use of three drugs, Pulmicort, Mucosolvan, and Montelukast can inhibit airway chronic inflammation more effectively and has a significant effect on reducing airway hyperresponsiveness and promoting endotracheal sputum dilution Effectively control cough symptoms.